Key facts
- This page summarizes Arturo Rodriguez's Form 4 filing for Aterian, Inc. (ATER).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 22 May 2026, 16:15.
Arturo Rodriguez - 21 May 2026 Form 4 Insider Report for Aterian, Inc. (ATER)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- ATER
- Reported as of
- 21 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 May 2026, 16:15:02 UTC
- Prior SEC filing
- 23 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Arturo Rodriguez
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Arturo Rodriguez filed Form 4 for Aterian, Inc. (ATER) on 22 May 2026.
Change
- Previous filing in this sequence was filed on 23 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001354895
Primary reporting owner
Rodriguez Arturo
- Relationship
- Chief Executive Officer, Director
- Address
- 350 SPRINGFIELD AVENUE SUITE #200, SUMMIT
- Signature
- /s/ Arturo Rodriguez
- Signature date
- 21 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATER
transaction
Common Stock
Award
- Transaction value
- Shares
- +70,000
- Change %
- +6.9%
- Price
- $0.000000*
- Shares after
- 1,081,148
- Date
- 21 May 2026
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Comprised of shares of restricted common stock granted pursuant to the Issuer's 2018 Equity Incentive Plan that are subject to vesting.
Footnote F2
The reported award was granted outside of the Company's regular annual equity grant cycle and was approved by the Compensation Committee for retention purposes.